CD86 and myeloid sarcoma: The levels of pro-inflammatory cytokines like TNFα (from astrocytes and M/M (CD86+)) and IL-1β (only from M/M (CD86+)) [72] are increased in cerebrospinal fluid and serum of MS patients, with a positive correlation with disease severity [73, 74].